EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs

Hae-Ri Lee, Soo Kim iD, Sungho Shin iD, Seon-Yeong Jeong, Dae-Won Lee, Sun-Ung Lim, Ji Yeon Kang, Mi-Young Son iD, Cheolju Lee iD, Kyung-Rok Yu iD, Myungshin Kim iD, Il-Hoan Oh

International Journal of Molecular Sciences · 03.01.2023 · 24 (1) · 881

DOI: 10.3390/ijms24010881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2023. Verfasst von Hae-Ri Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University, Seoul 06591, Republ…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Mesenchymal Stem Cells. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science ICT and Future Planning, Ministry of Food and Drug Safety, NRF of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stromal cells derived from induced pluripotent stem cells (iMSCs) have been proposed as alternative sources of primary MSCs with various advantages for cell therapeutic trials. However, precise evaluation of the differences between iMSCs and primary MSCs is lacking due to individual variations in the donor cells, which obscure direct comparisons between the two. In this study, we generated donor-matched iMSCs from individual bone marrow-derived MSCs and directly compared their cell-autonomous and paracrine therapeutic effects. We found that the transition from primary MSCs to iMSCs is accompanied by a functional shift towards higher proliferative activity, with variations in differentiation potential in a donor cell-dependent manner. The transition from MSCs to iMSCs was associated with common changes in transcriptomic and proteomic profiles beyond the variations of their individual donors, revealing expression patterns unique for the iMSCs. These iMSC-specific patterns were characterized by a shift in cell fate towards a pericyte-like state and enhanced secretion of paracrine cytokine/growth factors. Accordingly, iMSCs exhibited higher support for the self-renewing expansion of primitive hematopoietic progenitors and more potent immune suppression of allogenic immune responses than MSCs. Our study suggests that iMSCs represent a separate entity of MSCs with unique therapeutic potential distinct from their parental MSCs, but points to the need for iMSC characterization in the individual basis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsMesenchymal Stem CellsProteomicsCell DifferentiationSignal Transduction

Stichwörter der Autor:innen

cell autologouscell differentiationcell therapyiPSCmesenchymal stromal cells(MSCs)

Autor:innen und Institutionen

  • Catholic High-Performance Cell Therapy Center & Department of Medical Life Science, College of Medicine, The Catholic University, Seoul 06591, Republic of Korea.
  • Brexogen Research Center, Brexogen Inc., Songpa-gu, Seoul 05855, Republic of Korea.
  • Chemical & Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea.
  • Korean Research Institute for Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
  • Department of Agricultural Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul 08826, Republic of Korea.
  • Catholic Genetic Laboratory Center, Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

ORCID-Profile: Soo Kim, Sungho Shin, Mi-Young Son, Cheolju Lee, Kyung-Rok Yu, Myungshin Kim

Förderung

  • Ministry of Science ICT and Future Planning
  • Ministry of Food and Drug Safety
  • NRF of Korea
  • MFDS

Zitieren

APA

Lee, H. R., Kim, S., Shin, S., Jeong, S. Y., Lee, D. W., Lim, S. U., Kang, J. Y., Son, M. Y., Lee, C., Yu, K. R., Kim, M., & Oh, I. H. (2023). iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs. International Journal of Molecular Sciences, 24(1), 881. https://doi.org/10.3390/ijms24010881

Vancouver

Lee HR, Kim S, Shin S, Jeong SY, Lee DW, Lim SU, et al. iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs. International Journal of Molecular Sciences. 2023;24(1):881. doi:10.3390/ijms24010881

BibTeX
@article{Lee2023,
  author = {Lee, Hae-Ri and Kim, Soo and Shin, Sungho and Jeong, Seon-Yeong and Lee, Dae-Won and Lim, Sun-Ung and Kang, Ji Yeon and Son, Mi-Young and Lee, Cheolju and Yu, Kyung-Rok and Kim, Myungshin and Oh, Il-Hoan},
  title = {iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {1},
  pages = {881},
  doi = {10.3390/ijms24010881}
}
Kostenlos starten →